Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
about
PKCθ utility in diagnosing c-KIT/DOG-1 double negative gastrointestinal stromal tumors.A Potential New Therapeutic Approach to DMD: PKC Theta Inhibition.Effective regeneration of dystrophic muscle using autologous iPSC-derived progenitors with CRISPR-Cas9 mediated precise correction.Targeting early PKCθ-dependent T-cell infiltration of dystrophic muscle reduces disease severity in a mouse model of muscular dystrophy.
P2860
Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Pharmacological Inhibition of ...... f Duchenne Muscular Dystrophy.
@ast
Pharmacological Inhibition of ...... f Duchenne Muscular Dystrophy.
@en
type
label
Pharmacological Inhibition of ...... f Duchenne Muscular Dystrophy.
@ast
Pharmacological Inhibition of ...... f Duchenne Muscular Dystrophy.
@en
prefLabel
Pharmacological Inhibition of ...... f Duchenne Muscular Dystrophy.
@ast
Pharmacological Inhibition of ...... f Duchenne Muscular Dystrophy.
@en
P2093
P2860
P50
P1433
P1476
Pharmacological Inhibition of ...... f Duchenne Muscular Dystrophy.
@en
P2093
P2860
P304
P356
10.1016/J.EBIOM.2017.01.001
P577
2017-01-07T00:00:00Z